13G Filing: Sabby Capital and Aytu Bioscience Inc (AYTU)
Sabby Healthcare Master Fund, Ltd | 0 | 113,127 | 0 | 113,127 | 113,127 | 2.31 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 054754403 1.
Hedge Fund - Sabby Capital
News, Interviews, and Investor Letters
- First
- << Previous
- 21 - 30
- Next >>
13G Filing: Sabby Capital and Oncosec Medical Inc (ONCS)
Sabby Healthcare Master Fund, Ltd | 0 | 486,438 | 0 | 486,438 | 486,438 | 1.37 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 68234L207 1.
13G Filing: Sabby Capital and Superconductor Technologies Inc (SCON)
Sabby Healthcare Master Fund, Ltd | 0 | 536,887 | 0 | 536,887 | 536,887 | 4.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 867931503 1.
13G Filing: Sabby Capital and Neurometrix Inc. (NURO)
Sabby Healthcare Master Fund, Ltd | 0 | 211,908 | 0 | 211,908 | 211,908 | 9.03 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 641255708 1.
13G Filing: Sabby Capital and Arca Biopharma Inc. (ABIO)
Sabby Healthcare Master Fund, Ltd | 0 | 446,052 | 0 | 446,052 | 446,052 | 3.80 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 00211Y407 1.
13G Filing: Sabby Capital and Taxus Cardium Pharmaceuticals Group Inc. (CRXM)
Sabby Healthcare Master Fund, Ltd | 0 | 1,435,917 | 0 | 1,435,917 | 1,435,917 | 9.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 876767104 1.
13G Filing: Sabby Capital and Celsion Corp (CLSN)
Sabby Healthcare Master Fund, Ltd | 0 | 214,321 | 0 | 214,321 | 214,321 | 1.33 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 15117n305 1.
13D Filing: Sabby Capital and Strata Skin Sciences Inc. (SSKN)
Strata Skin Sciences Inc. (NASDAQ:SSKN): Hal Mintz's Sabby Capital filed an amended 13D.
You can check out Sabby Capital's latest holdings and filings here.
13G Filing: Sabby Capital and Inspiremd Inc. (NSPR)
Sabby Healthcare Master Fund, Ltd | 0 | 4,384,280 | 0 | 4,384,280 | 4,384,280 | 9.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 45779A804 1.
13G Filing: Sabby Capital and Vistagen Therapeutics Inc. (VTGN)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 9.15 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 92840H202 1.
- First
- << Previous
- 21 - 30
- Next >>